Safety, scrutiny and conflicts: assessing the fallout and lessons learned from pharmaceuticals.
Lanzafame
Raymond J
RJ
D016907:Adverse Drug Reaction Reporting Systems; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D017277:Drug Approval; D004345:Drug Industry; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D008402:Mass Media; D011358:Product Surveillance, Postmarketing; D013450:Sulfones / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib